Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation

被引:119
作者
Currier, GW
Simpson, GM
机构
[1] Univ Rochester, Dept Psychiat, Rochester, NY 14642 USA
[2] Univ Rochester, Dept Emergency Med, Rochester, NY 14642 USA
[3] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA USA
关键词
D O I
10.4088/JCP.v62n0303
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Although agitation associated with psychosis is a common presentation in the psychiatric emergency service, there is no consensus concerning the best treatment. Standard treatment often consists of intramuscular (i.m.) injection of high-potency neuroleptics. sometimes combined with benzodiazepines. The objective of this study was to determine the relative efficacy, safety, and tolerability of oral risperidone versus intramuscular haloperidol. both in combination with lorazepam, for the emergency treatment of psychotic agitation in patients who are able to accept oral medications.; Method: A convenience sample of psychotic patients admitted to a large psychiatric emergency service who required emergency medication for the control of agitation and/or violence was offered risperidone (2 mg liquid concentrate) and oral lorazepam (2 mg) as an alternative to standard care at the institution, haloperidol(5 mg i.m.) and lorazepam(2 mp i.m.). Subjects who refused the oral medications were given the intramuscular treatment as a component of routine care. Results: Thirty patients were enrolled in each treatment group. Although men were significantly more likely to choose oral medication (chi (2) = 5.165, p < .023), other demographic characteristics did not differ significantly between the 2 treatment groups. Both groups showed similar improvement in agitation as measured by 5 agitation subscales of the Positive and Negative: Syndrome Scale (PANSS). the Clinical Global Impressions (CGI) scale, and time to sedation. No patients receiving risperidone demonstrated any side effects or adverse events. while I patient receiving intramuscular treatment with haloperidol developed acute dystonia. One subject receiving risperidone required subsequent treatment with haloperidol for ongoing agitation. Conclusion: Oral treatment with risperidone and lorazepam appears to be a tolerable and comparable alternative to intramuscular haloperidol and lorazepam for short-term treatment of agitated psychosis in patients who accept oral medications.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 33 条
[21]   Risperidone for the treatment of behavioral disturbances in dementia: A case series [J].
Herrmann, N ;
Rivard, MF ;
Flynn, M ;
Ward, C ;
Rabheru, K ;
Campbell, B .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1998, 10 (02) :220-223
[22]  
Hillard JR, 1998, J CLIN PSYCHIAT, V59, P57
[23]   Risperidone treatment of behavioral disturbances in outpatients with dementia [J].
Irizarry, MC ;
Ghaemi, SN ;
Lee-Cherry, ER ;
Gomez-Isla, T ;
Binetti, G ;
Hyman, BT ;
Growdon, JH .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, 11 (03) :336-342
[24]   Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial [J].
Katz, IR ;
Jeste, DV ;
Mintzer, JE ;
Clyde, C ;
Napolitano, J ;
Brecher, M .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (02) :107-+
[25]   Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials [J].
Leucht, S ;
Pitschel-Walz, G ;
Abraham, D ;
Kissling, W .
SCHIZOPHRENIA RESEARCH, 1999, 35 (01) :51-68
[26]  
Levy RH, 1996, PHARMACOTHERAPY, V16, pS152
[27]   A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders [J].
McDougle, CJ ;
Holmes, JP ;
Carlson, DC ;
Pelton, GH ;
Cohen, DJ ;
Price, LH .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (07) :633-641
[28]  
*NAT I MENT HLTH, 1970, MAN ECDEU ASS BATT
[29]  
Pinals DA, 1999, J AM ACAD PSYCHIATRY, V27, P7
[30]  
RESNICK M, 1984, J CLIN PSYCHIAT, V45, P298